Effect of disease-modifying treatment on coronavirus disease 2019 vaccination in patients with multiple sclerosis

被引：0
|
作者：
D'haeseleer, M. [1 ]
Van Remoortel, A. [1 ]
D'hooghe, M. [1 ]
Della Faille, L. [1 ]
Nagels, G. [2 ,3 ]
Van Schependom, J. [4 ]
机构：
[1] Natl Multiple Sclerose Centrum NMSC, Melsbroek, Belgium
[2] Vrije Univ Brussel VUB, Ctr Neurosci C4N, NEUR, Brussels, Belgium
[3] Vrije Univ Brussel VUB, AIMS, Brussels, Belgium
[4] Vrije Univ Brussel VUB, Dept Elect & Informat ETRO, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-172
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [1] Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment
    De Troyer, Marijke
    Van Remoortel, Ann
    Van Schependom, Jeroen
    Della Faille, Laetitia
    D'hooghe, Marie B.
    Peeters, Gertjan
    Nagels, Guy
    D'haeseleer, Miguel
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [2] Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
    Sormani, Maria P.
    De Rossi, Nicola
    Schiavetti, Irene
    Carmisciano, Luca
    Cordioli, Cinzia
    Moiola, Lucia
    Radaelli, Marta
    Immovilli, Paolo
    Capobianco, Marco
    Trojano, Maria
    Zaratin, Paola
    Tedeschi, Gioacchino
    Comi, Giancarlo
    Battaglia, Mario A.
    Patti, Francesco
    Salvetti, Marco
    ANNALS OF NEUROLOGY, 2021, 89 (04) : 780 - 789
  • [3] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
  • [4] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    Current Treatment Options in Neurology, 2018, 20
  • [5] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [6] COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy
    Wolf, Andrew
    Alvarez, Enrique
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (04) : 358 - 361
  • [7] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [8] Prevalence of disease-modifying drug treatment gaps in patients with multiple sclerosis
    Joyeux, A.
    Kozma, C.
    Meletiche, D.
    Dickson, M.
    Bennett, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S163 - S163
  • [9] Disease-modifying treatment of secondary progressive multiple sclerosis
    Hoffmann, Olaf
    Gold, Ralf
    NERVENARZT, 2021, 92 (10): : 1052 - 1060
  • [10] Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies
    Murley, Chantelle
    Pettersson, Emma
    Hillert, Jan
    Machado, Alejandra
    Friberg, Emilie
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
12345